Based on the findings of previous in vivo and in vitro studies, HSP60 plays a dual role in tumor suppression and tumor generation; however, we found that low HSP60 expression of advanced-stage CRC is associated with poor prognosis, and the substantial association between HSP60 and p53 expression provides additional evidence to support this finding. This evidence concerns the gene HSPD1 and neoplasm.